
{
  "documentMetadata": {
    "title": "Pneumonia, Concomitant or Post Influenza",
    "sourceFile": "Pneumonia, Concomitant or Post Influenza.pdf",
    "lastUpdated": "2024-03-27"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Signs or symptoms of pneumonia or sepsis concomitant with or following influenza.",
        "Sputum gram stain useful for identifying Staph. aureus pneumonia post-influenza.",
        "Complicates 0.5 to 2.5% of influenza cases."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Staph. aureus",
        "Strep. pneumoniae",
        "Haemophilus influenzae",
        "Strep. pyogenes"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "notes": "In addition to coverage for both influenza and community-acquired pneumonia cover for MRSA",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h",
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)",
            "connector": "or"
          },
          {
            "drug": "Linezolid",
            "dose": "600 mg",
            "route": "IV",
            "frequency": "q12h"
          }
        ]
      }
    },
    {
      "type": "list",
      "items": [
        "For patients with MRSA risk factor (e.g., IVDU, prior positive culture for MRSA, inpatient parenteral antimicrobial therapy within 90 days) or with evidence of necrotizing pneumonia, hemoptysis, severe disease.",
        "Obtain sputum and blood cultures, which if negative MRSA coverage can be stopped."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "None"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "CDC surveillance data during the 2009 H1N1 influenza outbreak showed that pediatric deaths were associated with a documented bacterial infection in about a third of cases, 33% of which were Staph. aureus (both MSSA and MRSA) and 22% Strep. pneumoniae.",
        "About a third of patients admitted to the ICU and requiring mechanical ventilation had microbiological evidence of a concomitant bacterial pneumonia, predominantly due to Gram-positive cocci (Am J Respir Crit Care Med. 2021; 204:546)."
      ]
    }
  ]
}
